The costs and affordability of drug treatments for type 2 diabetes and hypertension in Vanuatu

Non-communicable diseases (NCDs), including diabetes and hypertension, pose increasingly significant health, policy and financing challenges in Vanuatu, a lower middle income Pacific Island country. Pharmaceutical costs to Government are becoming unsustainable. This report demonstrates that diabetes type 2 and hypertension are already putting unsustainable financial pressure on the pharmaceutical and broader health budget in Vanuatu.